Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,186 INR | -1.23% | -4.00% | +9.38% |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
May. 27 | Transcript : Aurobindo Pharma Limited, Q4 2024 Earnings Call, May 27, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.38% | 8.32B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Unit Gets US FDA's Final Approval for Generic Anfi-Fungal Drug